REGγ accelerates melanoma formation by regulating Wnt/β‐catenin signalling pathway
暂无分享,去创建一个
Geng Chen | Xiao Gao | Hui Chen | Jian Liu | Qingwei Wang | Lei Li | Tenghui Chen | Jiwei Chen | Zhengwang Sun | Tielong Liu | A. Shah | Y. Dang | Liangfang Yao | Ke Li | Kewen Hu | Lu Tong | Linian Pan | Tingmei Huang | Chan Jiao | Kun Li | Di Zuo | Bhatti Muhammad Zeeshan
[1] R. Moses,et al. REGγ is critical for skin carcinogenesis by modulating the Wnt/β-catenin pathway , 2015, Nature Communications.
[2] You-hong Cui,et al. High expression of REGγ is associated with metastasis and poor prognosis of patients with breast cancer. , 2014, International journal of clinical and experimental pathology.
[3] C. Creighton,et al. PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis. , 2014, Journal of molecular and cellular cardiology.
[4] Jing Hu,et al. Regulation of Wnt/β-catenin signaling by posttranslational modifications , 2014, Cell & Bioscience.
[5] Yunbo Shi,et al. The Mesobuthus martensii genome reveals the molecular diversity of scorpion toxins , 2014, Cell & Bioscience.
[6] L. Donehower,et al. REGγ deficiency promotes premature aging via the casein kinase 1 pathway , 2013, Proceedings of the National Academy of Sciences.
[7] R. Moon,et al. WNT signalling pathways as therapeutic targets in cancer , 2012, Nature Reviews Cancer.
[8] A. Veerman,et al. Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol , 2012, Journal of oncology.
[9] F. Tas. Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors , 2012, Journal of oncology.
[10] Tieliu Shi,et al. REGγ is associated with multiple oncogenic pathways in human cancers , 2012, BMC Cancer.
[11] Katherine M White,et al. A randomised controlled trial of a theory-based intervention to improve sun protective behaviour in adolescents ('you can still be HOT in the shade'): study protocol , 2012, BMC Cancer.
[12] C. Garbe,et al. β-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and Chemoresistance , 2011, PloS one.
[13] H. Mukhtar,et al. Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels. , 2011, The Journal of investigative dermatology.
[14] Guowu Yu,et al. Comparative analysis of REG{gamma} expression in mouse and human tissues. , 2010, Journal of molecular cell biology.
[15] Y. Matsuura,et al. Involvement of PA28γ in the propagation of hepatitis C virus , 2010, Hepatology.
[16] R. Moon,et al. Wnt and Related Signaling Pathways in Melanomagenesis , 2010, Cancers.
[17] R. Moon,et al. Activated Wnt/ß-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model , 2009, Proceedings of the National Academy of Sciences.
[18] P. Nuciforo,et al. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. , 2008, Cancer research.
[19] Ruiwen Zhang,et al. Proteasome activator PA28γ regulates p53 by enhancing its MDM2-mediated degradation , 2008, The EMBO journal.
[20] B. O’Malley,et al. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. , 2007, Molecular cell.
[21] A. Malovannaya,et al. The SRC-3/AIB1 Coactivator Is Degraded in a Ubiquitin- and ATP-Independent Manner by the REGγ Proteasome , 2006, Cell.
[22] I. Hisatome,et al. Abnormally high expression of proteasome activator-gamma in thyroid neoplasm. , 2003, The Journal of clinical endocrinology and metabolism.
[23] M. Sheikh,et al. Melanoma: Molecular Pathogenesis and Therapeutic Management. , 2014, Molecular and cellular pharmacology.
[24] L. Larue,et al. The WNT/Beta-catenin pathway in melanoma. , 2006, Frontiers in bioscience : a journal and virtual library.